{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:07:46Z","timestamp":1793689666481,"version":"4.5.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373937"],"award-info":[{"award-number":["82373937"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370158"],"award-info":[{"award-number":["82370158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2021YFA1100800"],"award-info":[{"award-number":["2021YFA1100800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2022453"],"award-info":[{"award-number":["2022453"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Fundamental Research Funds for the Central Universities"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70867-5","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:16:44Z","timestamp":1774973804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs"],"prefix":"10.1038","volume":"17","author":[{"given":"Mingqi","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husheng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuedong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshuo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-3591","authenticated-orcid":false,"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-8884","authenticated-orcid":false,"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8978-1987","authenticated-orcid":false,"given":"Aibin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7829-2547","authenticated-orcid":false,"given":"Qingsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-709X","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"70867_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn, L. H. & Salles, G. Diffuse large B-cell lymphoma. N. Engl. J. Med. 384, 842\u2013858 (2021).","journal-title":"N. Engl. J. Med."},{"key":"70867_CR2","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","volume":"377","author":"SJ Schuster","year":"2017","unstructured":"Schuster, S. J. et al. Chimeric antigen receptor T cells in refractory B-cell lymphomas. N. Engl. J. Med. 377, 2545\u20132554 (2017).","journal-title":"N. Engl. J. Med."},{"key":"70867_CR3","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","volume":"377","author":"SS Neelapu","year":"2017","unstructured":"Neelapu, S. S. et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N. Engl. J. Med. 377, 2531\u20132544 (2017).","journal-title":"N. Engl. J. Med."},{"key":"70867_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439\u2013448 (2018).","journal-title":"N. Engl. J. Med."},{"key":"70867_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S. L. et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N. Engl. J. Med. 371, 1507\u20131517 (2014).","journal-title":"N. Engl. J. Med."},{"key":"70867_CR6","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1038\/s41375-020-0811-3","volume":"34","author":"K Nakamura","year":"2020","unstructured":"Nakamura, K. et al. Targeting an adenosine-mediated \u201cdon\u2019t eat me signal\u201d augments anti-lymphoma immunity by anti-CD20 monoclonal antibody. Leukemia 34, 2708\u20132721 (2020).","journal-title":"Leukemia"},{"key":"70867_CR7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3389\/fimmu.2020.01109","volume":"11","author":"A Rodriguez-Garcia","year":"2020","unstructured":"Rodriguez-Garcia, A., Palazon, A., Noguera-Ortega, E., Powell, D. J. Jr. & Guedan, S. CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape. Front Immunol. 11, 1109 (2020).","journal-title":"Front Immunol."},{"key":"70867_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi, Y., Shitara, K. & Nishikawa, H. Regulatory T cells in cancer immunosuppression\u2014implications for anticancer therapy. Nat. Rev. Clin. Oncol. 16, 356\u2013371 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"70867_CR9","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1182\/bloodadvances.2020002394","volume":"4","author":"FL Locke","year":"2020","unstructured":"Locke, F. L. et al. Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma. Blood Adv. 4, 4898\u20134911 (2020).","journal-title":"Blood Adv."},{"key":"70867_CR10","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1200\/JCO.19.02103","volume":"38","author":"CA Jacobson","year":"2020","unstructured":"Jacobson, C. A. et al. Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity. J. Clin. Oncol. 38, 3095\u20133106 (2020).","journal-title":"J. Clin. Oncol."},{"key":"70867_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).","journal-title":"Blood Cancer J."},{"key":"70867_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41573-023-00807-1","volume":"22","author":"M Ruella","year":"2023","unstructured":"Ruella, M., Korell, F., Porazzi, P. & Maus, M. V. Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies. Nat. Rev. Drug Discov. 22, 976\u2013995 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70867_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","volume":"38","author":"S Sakaguchi","year":"2020","unstructured":"Sakaguchi, S. et al. Regulatory T cells and human disease. Annu. Rev. Immunol. 38, 541\u2013566 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"70867_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"AY Rudensky","year":"2011","unstructured":"Rudensky, A. Y. Regulatory T cells and Foxp3. Immunol. Rev. 241, 260\u2013268 (2011).","journal-title":"Immunol. Rev."},{"key":"70867_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni1455","volume":"8","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. & Rudensky, A. Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457\u2013462 (2007).","journal-title":"Nat. Immunol."},{"key":"70867_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1056\/NEJMoa1804980","volume":"380","author":"SJ Schuster","year":"2019","unstructured":"Schuster, S. J. et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N. Engl. J. Med. 380, 45\u201356 (2019).","journal-title":"N. Engl. J. Med."},{"key":"70867_CR17","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41591-022-01960-7","volume":"28","author":"Z Good","year":"2022","unstructured":"Good, Z. et al. Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy. Nat. Med. 28, 1860\u20131871 (2022).","journal-title":"Nat. Med."},{"key":"70867_CR18","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/s41591-022-01959-0","volume":"28","author":"NJ Haradhvala","year":"2022","unstructured":"Haradhvala, N. J. et al. Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma. Nat. Med. 28, 1848\u20131859 (2022).","journal-title":"Nat. Med."},{"key":"70867_CR19","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41591-022-01998-7","volume":"28","author":"N Saini","year":"2022","unstructured":"Saini, N. & Neelapu, S. S. CAR Treg cells: prime suspects in therapeutic resistance. Nat. Med. 28, 1755\u20131756 (2022).","journal-title":"Nat. Med."},{"key":"70867_CR20","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1172\/JCI64859","volume":"123","author":"A Marabelle","year":"2013","unstructured":"Marabelle, A. et al. Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J. Clin. Invest 123, 2447\u20132463 (2013).","journal-title":"J. Clin. Invest"},{"key":"70867_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2019.10.032","volume":"469","author":"R Wang","year":"2020","unstructured":"Wang, R. et al. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model. Cancer Lett. 469, 151\u2013161 (2020).","journal-title":"Cancer Lett."},{"key":"70867_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41375-018-0242-6","volume":"33","author":"Y-T Tai","year":"2019","unstructured":"Tai, Y.-T. et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia 33, 426\u2013438 (2019).","journal-title":"Leukemia"},{"key":"70867_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14471-1","volume":"11","author":"M Sharma","year":"2020","unstructured":"Sharma, M. et al. Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy. Nat. Commun. 11, 661 (2020).","journal-title":"Nat. Commun."},{"key":"70867_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/eji.202048992","volume":"51","author":"S Dees","year":"2021","unstructured":"Dees, S., Ganesan, R., Singh, S. & Grewal, I. S. Regulatory T cell targeting in cancer: emerging strategies in immunotherapy. Eur. J. Immunol. 51, 280\u2013291 (2021).","journal-title":"Eur. J. Immunol."},{"key":"70867_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.copbio.2014.09.002","volume":"30","author":"Y Luo","year":"2014","unstructured":"Luo, Y., Cobb, R. E. & Zhao, H. Recent advances in natural product discovery. Curr. Opin. Biotechnol. 30, 230\u2013237 (2014).","journal-title":"Curr. Opin. Biotechnol."},{"key":"70867_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","volume":"14","author":"AL Harvey","year":"2015","unstructured":"Harvey, A. L., Edrada-Ebel, R. & Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111\u2013129 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70867_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov, A. G. et al. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200\u2013216 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70867_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/jocd.13035","volume":"19","author":"AR Im","year":"2020","unstructured":"Im, A. R. et al. Clinical evaluation of the safety and efficacy of a timosaponin A-III-based antiwrinkle agent against skin aging. J. Cosmet. Dermatol 19, 423\u2013436 (2020).","journal-title":"J. Cosmet. Dermatol"},{"key":"70867_CR29","doi-asserted-by":"crossref","unstructured":"Lin, Y. et al. Pharmacological activity, pharmacokinetics, and toxicity of timosaponin AIII, a natural product isolated from Anemarrhena asphodeloides Bunge: a review. Front. Pharmacol. 11, 764 (2020).","DOI":"10.3389\/fphar.2020.00764"},{"key":"70867_CR30","doi-asserted-by":"crossref","unstructured":"Tu, H. et al. Anti-tumor effect and mechanisms of Timosaponin AIII across diverse cancer progression. Biochem. Pharmacol. 228, 116080 (2024).","DOI":"10.1016\/j.bcp.2024.116080"},{"key":"70867_CR31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.intimp.2015.02.016","volume":"25","author":"S-M Lim","year":"2015","unstructured":"Lim, S.-M. et al. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-\u03baB and MAPK activation and restoring Th17\/Treg cell balance. Int. Immunopharmacol. 25, 493\u2013503 (2015).","journal-title":"Int. Immunopharmacol."},{"key":"70867_CR32","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1182\/blood-2020-140907","volume":"136","author":"C Tong","year":"2020","unstructured":"Tong, C. et al. Optimized tandem CD19\/CD20 CAR-engineered T cells in refractory\/relapsed B-cell lymphoma. Blood 136, 1632\u20131644 (2020).","journal-title":"Blood"},{"key":"70867_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ccell.2024.01.002","volume":"42","author":"DD Klysz","year":"2024","unstructured":"Klysz, D. D. et al. Inosine induces stemness features in CAR-T cells and enhances potency. Cancer Cell 42, 266\u2013282.e268 (2024).","journal-title":"Cancer Cell"},{"key":"70867_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov, H., Orhan, A., Christensen, J. P. & G\u00f6genur, I. Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. Br. J. Cancer 124, 359\u2013367 (2021).","journal-title":"Br. J. Cancer"},{"key":"70867_CR35","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.chembiol.2020.06.011","volume":"27","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Pharmacological targeting of Vacuolar H(+)-ATPase via subunit V1G combats multidrug-resistant cancer. Cell Chem. Biol. 27, 1359\u20131370.e1358 (2020).","journal-title":"Cell Chem. Biol."},{"key":"70867_CR36","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/ijms15022024","volume":"15","author":"S Sheth","year":"2014","unstructured":"Sheth, S., Brito, R., Mukherjea, D., Rybak, L. P. & Ramkumar, V. Adenosine receptors: expression, function and regulation. Int. J. Mol. Sci. 15, 2024\u20132052 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"70867_CR37","doi-asserted-by":"crossref","unstructured":"Carpenter, B. & Lebon, G. Human adenosine A2A receptor: molecular mechanism of ligand binding and activation. Front. Pharmacol. 8, 898 (2017).","DOI":"10.3389\/fphar.2017.00898"},{"key":"70867_CR38","doi-asserted-by":"crossref","unstructured":"McGraw, C., Koretz, K.S., Oseid, D., Lyman, E. & Robinson, A.S.J.M. Cholesterol dependent activity of the adenosine A2a receptor is modulated via the cholesterol consensus motif. Molecules 27, 3529 (2022).","DOI":"10.3390\/molecules27113529"},{"key":"70867_CR39","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbamem.2019.01.001","volume":"1861","author":"C McGraw","year":"2019","unstructured":"McGraw, C., Yang, L., Levental, I., Lyman, E. & Robinson, A. S. Membrane cholesterol depletion reduces downstream signaling activity of the adenosine A(2A) receptor. Biochim Biophys. Acta Biomembr. 1861, 760\u2013767 (2019).","journal-title":"Biochim Biophys. Acta Biomembr."},{"key":"70867_CR40","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.2147\/IJN.S313759","volume":"16","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. Novel timosaponin AIII-based multifunctional liposomal delivery system for synergistic therapy against hepatocellular carcinoma cancer. Int. J. Nanomed. 16, 5531\u20135550 (2021).","journal-title":"Int. J. Nanomed."},{"key":"70867_CR41","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.apsb.2023.12.004","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies. Acta Pharmaceutica Sin. B 14, 1951\u20131964 (2024).","journal-title":"Acta Pharmaceutica Sin. B"},{"key":"70867_CR42","doi-asserted-by":"publisher","first-page":"14928","DOI":"10.3390\/ijms241914928","volume":"24","author":"J Xing","year":"2023","unstructured":"Xing, J., Zhang, J. & Wang, J. The immune regulatory role of adenosine in the tumor microenvironment. Int. J. Mol. Sci. 24, 14928 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"70867_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14737140.2017.1316197","volume":"17","author":"TL Whiteside","year":"2017","unstructured":"Whiteside, T. L. Targeting adenosine in cancer immunotherapy: a review of recent progress. Expert Rev. Anticancer Ther. 17, 527\u2013535 (2017).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"70867_CR44","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","volume":"5","author":"A Ohta","year":"2014","unstructured":"Ohta, A. & Sitkovsky, M. Extracellular adenosine-mediated modulation of regulatory T cells. Front Immunol. 5, 304 (2014).","journal-title":"Front Immunol."},{"key":"70867_CR45","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.4049\/jimmunol.1000108","volume":"185","author":"PB Ernst","year":"2010","unstructured":"Ernst, P. B., Garrison, J. C. & Thompson, L. F. Much Ado about adenosine: adenosine synthesis and function in regulatory T cell biology. J. Immunol. 185, 1993\u20131998 (2010).","journal-title":"J. Immunol."},{"key":"70867_CR46","doi-asserted-by":"crossref","unstructured":"Gitto, S., Natalini, A., Antonangeli, F. & Di Rosa, F. The emerging interplay between recirculating and tissue-resident memory T cells in cancer immunity: lessons learned from PD-1\/PD-L1 blockade therapy and remaining gaps. Front. Immunol. 12 755304 (2021).","DOI":"10.3389\/fimmu.2021.755304"},{"key":"70867_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.cpt.2022.12.002","volume":"1","author":"H Ahmed","year":"2023","unstructured":"Ahmed, H. et al. Role of T cells in cancer immunotherapy: Opportunities and challenges. Cancer Pathogenesis Ther. 1, 116\u2013126 (2023).","journal-title":"Cancer Pathogenesis Ther."},{"key":"70867_CR48","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/ijms25052914","volume":"25","author":"J-H Park","year":"2024","unstructured":"Park, J.-H. et al. Timosaponin A3 induces anti-obesity and anti-diabetic effects in vitro and in vivo. Int. J. Mol. Sci. 25, 2914 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"70867_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng, H. et al. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499, 485\u2013490 (2013).","journal-title":"Nature"},{"key":"70867_CR50","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ccell.2024.05.013","volume":"42","author":"SN Geels","year":"2024","unstructured":"Geels, S. N. et al. Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy. Cancer Cell 42, 1051\u20131066.e1057 (2024).","journal-title":"Cancer Cell"},{"key":"70867_CR51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1084\/jem.20130904","volume":"211","author":"VS Cortez","year":"2014","unstructured":"Cortez, V. S. et al. CRTAM controls residency of gut CD4+CD8+ T cells in the steady state and maintenance of gut CD4+ Th17 during parasitic infection. J. Exp. Med. 211, 623\u2013633 (2014).","journal-title":"J. Exp. Med."},{"key":"70867_CR52","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1182\/blood-2005-02-0817","volume":"106","author":"KS Boles","year":"2005","unstructured":"Boles, K. S., Barchet, W., Diacovo, T., Cella, M. & Colonna, M. The tumor suppressor TSLC1\/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood 106, 779\u2013786 (2005).","journal-title":"Blood"},{"key":"70867_CR53","doi-asserted-by":"crossref","unstructured":"Salas-Benito, D., Berger, T.R. & Maus, M.V. Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies. 7, 23-42 (2023).","DOI":"10.1146\/annurev-cancerbio-061421-012235"},{"key":"70867_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fonc.2019.00279","volume":"9","author":"S Han","year":"2019","unstructured":"Han, S., Toker, A., Liu, Z. Q. & Ohashi, P. S. Turning the tide against regulatory T cells. Front Oncol. 9, 279 (2019).","journal-title":"Front Oncol."},{"key":"70867_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang, M., Lu, J.-J. & Ding, J. Natural products in cancer therapy: past, present and future. Nat. Products Bioprospecting 11, 5\u201313 (2021).","journal-title":"Nat. Products Bioprospecting"},{"key":"70867_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5794350","volume":"2022","author":"YO Ali Abdalla","year":"2022","unstructured":"Ali Abdalla, Y. O. et al. Natural products for cancer therapy: a review of their mechanism of actions and toxicity in the past decade. J. tropical Med. 2022, 5794350 (2022).","journal-title":"J. tropical Med."},{"key":"70867_CR57","doi-asserted-by":"publisher","first-page":"7862782","DOI":"10.1155\/2018\/7862782","volume":"2018","author":"K Wang","year":"2018","unstructured":"Wang, K., Conlon, M., Ren, W., Chen, B. B. & B\u0105czek, T. Natural products as targeted modulators of the immune system. J. Immunol. Res. 2018, 7862782 (2018).","journal-title":"J. Immunol. Res."},{"key":"70867_CR58","volume":"59","author":"KY Ji","year":"2019","unstructured":"Ji, K. Y. et al. The enhancing immune response and anti-inflammatory effects of Anemarrhena asphodeloides extract in RAW 264.7 cells. Phytomedicine Int. J. Phytother. Phytopharmacol. 59, 152789 (2019).","journal-title":"Phytomedicine Int. J. Phytother. Phytopharmacol."},{"key":"70867_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.steroids.2019.03.009","volume":"146","author":"XY Song","year":"2019","unstructured":"Song, X. Y. et al. Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo. Steroids 146, 57\u201364 (2019).","journal-title":"Steroids"},{"key":"70867_CR60","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Cantillo, G., Urue\u00f1a, C., Camacho, B.A. & Ram\u00edrez-Segura, C. CAR-T Cell Performance: How to Improve Their Persistence? Front Immunol. 13, 878209 (2022).","DOI":"10.3389\/fimmu.2022.878209"},{"key":"70867_CR61","doi-asserted-by":"crossref","unstructured":"Zhang, H. et al. The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy. Front Immunol. 14, 1154566 (2023).","DOI":"10.3389\/fimmu.2023.1154566"},{"key":"70867_CR62","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s11864-023-01049-4","volume":"24","author":"X Cao","year":"2023","unstructured":"Cao, X. et al. Small-molecule compounds boost CAR-T cell therapy in hematological malignancies. Curr. Treat. options Oncol. 24, 184\u2013211 (2023).","journal-title":"Curr. Treat. options Oncol."},{"key":"70867_CR63","doi-asserted-by":"crossref","unstructured":"Harrer, D.C., D\u00f6rrie, J. & Schaft, N. CARs and Drugs: pharmacological ways of boosting CAR-T-cell therapy. Int. J. Mol. Sci. 24, 2342 (2023).","DOI":"10.3390\/ijms24032342"},{"key":"70867_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20671-6","volume":"12","author":"S Park","year":"2021","unstructured":"Park, S. et al. Direct control of CAR T cells through small molecule-regulated antibodies. Nat. Commun. 12, 710 (2021).","journal-title":"Nat. Commun."},{"key":"70867_CR65","doi-asserted-by":"crossref","unstructured":"Huang, L. & Zhang, C. Microscale thermophoresis (MST) to detect the interaction between purified proteins and small molecules. in Plant Chemical Genomics: Methods and Protocols (eds. Hicks, G.R. & Zhang, C.) 187\u2013193 (Springer US, New York, NY, 2021).","DOI":"10.1007\/978-1-0716-0954-5_17"},{"key":"70867_CR66","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41392-022-01240-3","volume":"8","author":"H Mei","year":"2023","unstructured":"Mei, H. et al. Discovery of IHMT\u2212337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. Signal Transduct. Target. Ther. 8, 18 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70867_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22980-w","volume":"12","author":"EJ Hsu","year":"2021","unstructured":"Hsu, E. J. et al. A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy. Nat. Commun. 12, 2768 (2021).","journal-title":"Nat. Commun."},{"key":"70867_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0703-7","volume":"18","author":"MG Garc\u00eda-Mendoza","year":"2016","unstructured":"Garc\u00eda-Mendoza, M. G. et al. Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment. Breast Cancer Res. 18, 49 (2016).","journal-title":"Breast Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70867-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70867-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:14:59Z","timestamp":1774984499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70867-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70867"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70867-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3045"}}